Navican provides a personalized approach to testing, diagnosing, and treating cancer. Our unique process analyzes the genetic makeup of a patient’s cancer and employs a team of skilled molecular tumor specialists to review each test and determine how to most effectively treat that cancer case. Our team approach gives oncologists the information and support they need to prepare a customized, targeted treatment plan for each patient.
Starting April 1, 2017, all testing and medication ordering services will shift to Navican. Until then, please continue to order the ICG100™ test through Intermountain Precision Genomics website.